EN | ES
Salvat
  • Salvat
  • Activities
  • Partnering & Services
  • Products
  • Commitment
  • Careers
  • Media
  • Connect
  • Menu

Salvat’s News and Press kit

Media

Salvat at a glance

Press Kit

What are we doing right now

News

Media

Press Kit

Salvat at a glance

If you are a media professional and wish to receive more information, please send us an email at media@svt.com.

YOU CAN DOWNLOAD OUR PRESS KIT HERE:

SALVAT PRESS KIT

English Version PDF

Download

News

What are we doing right now

Salvat’s Pharmaloop Invests 65 million Euros in Its New Sterile Liquids Plant, located in Alcalá de Henares

18/02/2021/in Salvat International, Salvat Spain, Salvat USA /by Carme Lopez

The Minister of Industry, Reyes Maroto, visited Salvat’s new facility today, accompanied by the Mayor of Alcalá de Henares, Javier Rodriguez Palacios and Salvat CEO, Alberto Bueno The new 8,500 m² plant is equipped with the most advanced technology, highest quality standards and the capacity to produce more than 350 million units of sterile formulations […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 Carme Lopez https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png Carme Lopez2021-02-18 13:52:482021-02-18 14:08:52Salvat’s Pharmaloop Invests 65 million Euros in Its New Sterile Liquids Plant, located in Alcalá de Henares

Salvat Laboratories enters in the chinese market with Cetraxal® Plus Clinical Trial

01/02/2021/in Salvat International, Salvat Spain, Salvat USA /by Carme Lopez

Salvat has an agreement with Lee’s Pharmaceuticals to distribute Cetraxal® Plus in China Cetraxal® Plus is the only pharmaceutical product in the world that is available in single-dose vials for external otitis and otitis media. It was launched in 2002 in Spain and is already exported to more than 50 countries The Phase III clinical […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 Carme Lopez https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png Carme Lopez2021-02-01 13:48:422021-02-04 11:40:40Salvat Laboratories enters in the chinese market with Cetraxal® Plus Clinical Trial

Herpix®, the new oral formula against the Herpes Simplex Virus from Laboratorios Salvat, is chosen as Product of the Year 2021

25/01/2021/in Salvat International, Salvat Spain, Salvat USA /by Carme Lopez

The new product from Laboratorios Salvat has been recognised as this year’s most innovative Food Supplement for the Immune System Herpix® is a food supplement formulated from natural extracts which helps slow the replication of the Herpes Simplex Virus (HSV), acting from the inside right from the appearance of the first symptom Herpix®, the new […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 Carme Lopez https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png Carme Lopez2021-01-25 10:38:252021-01-25 10:38:25Herpix®, the new oral formula against the Herpes Simplex Virus from Laboratorios Salvat, is chosen as Product of the Year 2021

Salvat pioneers advancement in the treatment of non-consolidated bone fractures (BONECURE project)

24/07/2020/in Salvat International, Salvat Spain, Salvat USA /by Carme Lopez

Salvat’s new BONECURE project is an innovative medical advancement based on pre-differentiated mesenchymal cells designed to treat patients with bone consolidation problems post-fracture (atrophic pseudoarthrosis). A Phase II clinical trial is being completed with promising results in terms of both efficacy and safety, in patients with long bone pseudoarthrosis. Salvat has conducted this project in […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 Carme Lopez https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png Carme Lopez2020-07-24 13:33:582020-07-24 13:33:58Salvat pioneers advancement in the treatment of non-consolidated bone fractures (BONECURE project)

Cristalmina increases production sevenfold and prepares to launch in international market

21/07/2020/in Salvat International, Salvat Spain, Salvat USA /by Carme Lopez

A new automated robotic line costing more than €6 million has enabled Cristalmina to increase production from 2.5 million to 15 million units per year By 2021, the company plans to have authorisation to market Cristalmina in more than 26 European countries, which will be followed by Asia and the USA in the years to […]

Read more
https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png 0 0 Carme Lopez https://svt.com/wp-content/uploads/2017/12/salvat-logo-263x68.png Carme Lopez2020-07-21 12:31:372020-07-21 12:31:54Cristalmina increases production sevenfold and prepares to launch in international market
Page 3 of 6‹12345›»

CATEGORIES

  • Salvat Foundation
  • Salvat International
  • Salvat Spain
  • Salvat USA

LATEST NEWS

  • Salvat Laboratories initiates a pioneering pediatric study in Europe with its innovative drug SVT-15473, for the treatment of inflammation and pain following ocular surgery07/07/2023 - 6:47 am

    Phase III clinical trials conducted in adults confirm the efficacy and excellent safety profile of SVT-15473 ophthalmic clobetasol, formulated with IMPACT-SVT® patented nanoemulsion technology, for the treatment of inflammation and pain following ocular surgery. This is the first clinical study conducted in Europe in pediatric patients with a topical ophthalmic corticosteroid. With the new study, […]

  • Salvat Laboratories presented Phase III clinical trials results of Clobetasol Nanoemulsion for treating inflammation and pain after ocular surgery at the 2023 ARVO Annual Meeting24/05/2023 - 8:47 am

    Salvat Laboratories, the international pharmaceutical company focused on the development, manufacturing, and commercialization of ophthalmology treatments, announced the results of phase III clinical trials of its most potent ophthalmic corticosteroid in the global ophthalmology market at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting held from 23-27 April 2023 in New Orleans. […]

  • Salvat Laboratory submits application to the U.S. FDA for approval of Clotrimazole, a pioneering drug for the treatment of otomycosis01/12/2022 - 8:43 am

    The new drug will be the only one on the market in the United States and Europe specifically formulated and indicated for the topical treatment of fungal otitis externa. Salvat has invested 22 million euros in this project with which reinforces its position as a leading laboratory in the field of otology at an international […]

  • Salvat
  • Mission, Vision & Values
  • The Company
  • Our History
  • Salvat USA
  • Salvat Worldwide
  • Our People
  • Activities
  • R+D
  • Product Pipeline
  • Partnering
  • Manufacturing
  • Pharmaloop
  • Sales
  • Partnering & Services
  • Licensing and Partnership
  • CDMO Services
  • Innovation and Technology
  • Meet Us
  • Products
  • Otolaryngology
  • Ophthalmology
  • Gastroenterology
  • Other Therapeutic Areas
  • Consumer Healthcare
  • Full Product List
  • Commitment
  • Corporate Citizenship
  • Transparency
  • Memberships
  • Salvat Foundation
  • Careers
  • Working at Salvat
  • Send your CV
  • Media
  • Press Kit
  • News
  • Connect
  • Contact Us
  • Salvat Replies
  • Disclaimer
  • Cookies
  • © Salvat 2020, All Rights Reserved
  • Twitter
  • Linkedin
  • Facebook

Usamos 'cookies' para personalizar el contenido y analizar el uso de nuestro sitio web. Si hace clic en "Aceptar", da su consentimiento para el uso de éstas y navegará directamente a la página web. Si no quiere aceptar algunas de las ‘cookies’ o quiere saber más acerca de cómo usamos las ‘cookies’, haga click en “Personalizar”.

VER POLÍTICA DE  COOKIES


We use 'cookies' to personalize content and analyze the use of our website. By clicking "I Accept", you consent to their use and will navigate directly to the website. If you do not want to accept some of the ‘cookies’ or want to know more about how we use the ‘cookies, click on“ Personalize”.

VIEW COOKIES POLICY

ACEPTAR / I ACCEPTPERSONALIZAR / PERSONALIZE
Manage consent

Personalizar / Personalize

Aquí puede elegir las cookies que se guardan en su navegador:
Here you can select the cookies allowed to be stored on your browser:
Analytics
These cookies collect information about how visitors make use of the website, such as page views, loading errors… It is generic and anonymous information where personal data are not included nor collects information that identifies visitors; with the ultimate aim to improve the functioning of the website.

CookieDurationDescription
_ga2 yearsGoogle Analytics
_gat_gtag_UA_112188601_12 yearsGoogle Analytics
_gid2 yearsGoogle Analytics
Necessary
Always Enabled
These cookies are necessary for the proper use of the website, allowing access to sections that have security filters. Without these cookies, many of the features would not be operating.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
ip2location_redirection_first_visitsessionMostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language
PHPSESSIDsessionIdentificador de sesión PHP / PHP session id
prescriptionModalAcceptedsessionIdentificador de sesión PHP / PHP session id
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
wpml_browser_redirect_testsessionMostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language
_icl_visitor_lang_jssessionMostrar las páginas de la web en el idioma seleccionado / Browse this website pages in the selected language
SAVE & ACCEPT
  Scroll to top